In the fast-moving world of oncology, organisations must quickly interpret performance metrics across multiple brands, geographies, and channels. This DelveInsight case study highlights an oncology product assessment dashboard developed for a global pharmaceutical company, enabling real-time monitoring of new-asset performance through integrated lead and lag KPIs. The mission: transform scattered data into strategic clarity by unifying metrics, reducing interpretation delays, and empowering informed decision-making.
➡️ Explore the full case study here:
https://www.delveinsight.com/case-study/oncology-product-assessment-dashboard?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr
Problem Statement: “When Delayed Data Becomes Strategic Risk”
The client was managing multiple newly launched oncology products across several locally operating countries (LOCs). Their major challenges included:
Irregular and delayed reporting of lead indicators such as sales volume, patient volume, patient share, and market share across treatment lines.
Lag indicators — awareness, share of voice, coverage, market access, treatment duration, and dosage metrics — were fragmented and lacked visualisation.
Absence of a unified platform to compare country-wise performance (monthly, quarterly, annually), resulting in delayed identification of under-performing markets or brands.
Our Methodology: “Turning Data Silos into a Unified View”
DelveInsight addressed these issues through a streamlined, collaborative approach:
Implemented structured tracking of lead KPIs, including sales, volume, patient count, patient share, and market share by line.
Mapped all essential lag KPIs such as awareness, share of voice, market access, coverage, treatment duration, and dose metrics.
Built a centralised data repository in coordination with LOC teams to ensure timely, standardised inflow of data.
Conducted comprehensive data sanity checks before dashboard deployment to ensure accuracy and reliability.
This resulted in a dynamic, web-based KPI dashboard offering impactful visualisations, monthly executive summaries, and performance evolution indices to compare individual countries.
➡️ See how DelveInsight transforms complex oncology data into strategic advantage:
https://www.delveinsight.com/case-study/oncology-product-assessment-dashboard?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr
Results: “Sharper Insights. Faster Decisions. Stronger Outcomes.”
DelveInsight’s dashboard solution delivered the client:
A unified, interactive KPI dashboard with all required visualisations and monthly executive performance summaries across brands and countries.
A faster feedback mechanism enabling LOC teams to assess real-time performance, detect issues quickly, and address gaps proactively.
A powerful “evolution index” allowing clear benchmarking of country-wise performance, highlighting both top performers and areas needing attention.
Enhanced visibility into high- and low-performing brands/markets across various lines, supporting smart resource allocation and strategic prioritisation.
DelveInsight’s oncology product assessment dashboard transformed a complex multi-country data ecosystem into a strategic intelligence powerhouse — delivering clarity, comparability, and actionable insight through a single, unified interface.
➡️ Access the complete case study now:
https://www.delveinsight.com/case-study/oncology-product-assessment-dashboard?utm_source=casestudy&utm_medium=promotion&utm_campaign=mpr